Literature DB >> 3035052

Leukotriene release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhoea and menorrhagia.

M C Rees, V DiMarzo, J R Tippins, H R Morris, A C Turnbull.   

Abstract

Endometrium and myometrium were collected at hysterectomy from 21 women with measured menstrual blood loss. Eight women complained of dysmenorrhea and the remaining 13 had pain-free periods. Specimens were obtained throughout the menstrual cycle (menstrual, n = 5; follicular, n = 4; early luteal, n = 3; mid-luteal, n = 5; late luteal, n = 4). Leukotriene C4, leukotriene D4 and leukotriene E4 release were examined using a short-term incubation technique. Endometrial leukotriene release, which was always significantly greater than myometrial release, changed throughout the menstrual cycle and the highest concentrations were found during menstruation. Endometrial, but not myometrial, leukotriene concentrations were significantly higher in tissues obtained from women with a complaint of dysmenorrhoea compared with those in tissue from pain-free women. No correlation was found between leukotriene release in either endometrium or myometrium and menstrual blood loss (range 15-457 ml).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3035052     DOI: 10.1677/joe.0.1130291

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  13 in total

1.  Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding.

Authors:  Magdalena Bofill Rodriguez; Anne Lethaby; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2019-09-19

2.  Adult-onset asthma is associated with increased carotid atherosclerosis among women in the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Stephen Onufrak; Jerome Abramson; Viola Vaccarino
Journal:  Atherosclerosis       Date:  2006-10-10       Impact factor: 5.162

Review 3.  Treatment of dysmenorrhoea and premenstrual syndrome with non-steroidal anti-inflammatory drugs.

Authors:  S S Shapiro
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

4.  Menstrual pain and epithelial ovarian cancer risk.

Authors:  Ana Babic; Daniel W Cramer; Linda J Titus; Shelley S Tworoger; Kathryn L Terry
Journal:  Cancer Causes Control       Date:  2014-09-05       Impact factor: 2.506

Review 5.  A contemporary approach to dysmenorrhea in adolescents.

Authors:  Zeev Harel
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

6.  Orally administered tolfenamic acid inhibits leukotriene synthesis in isolated human peripheral polymorphonuclear leukocytes.

Authors:  E Moilanen; J Alanko; A Juhakoski; H Vapaatalo
Journal:  Agents Actions       Date:  1989-08

Review 7.  Risk-benefit assessment of drugs used for the treatment of menstrual disorders.

Authors:  J M Higham; R W Shaw
Journal:  Drug Saf       Date:  1991 May-Jun       Impact factor: 5.606

Review 8.  Benefits and risks of pharmacological agents used for the treatment of menorrhagia.

Authors:  Samendra Nath Roy; Siladitya Bhattacharya
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 9.  Nonsteroidal antiinflammatory drug resistance in dysmenorrhea: epidemiology, causes, and treatment.

Authors:  Folabomi A Oladosu; Frank F Tu; Kevin M Hellman
Journal:  Am J Obstet Gynecol       Date:  2017-09-06       Impact factor: 8.661

10.  Menstrual pain and risk of epithelial ovarian cancer: Results from the Ovarian Cancer Association Consortium.

Authors:  Ana Babic; Holly R Harris; Allison F Vitonis; Linda J Titus; Susan J Jordan; Penelope M Webb; Harvey A Risch; Mary Anne Rossing; Jennifer A Doherty; Kristine Wicklund; Marc T Goodman; Francesmary Modugno; Kirsten B Moysich; Roberta B Ness; Susanne K Kjaer; Joellen Schildkraut; Andrew Berchuck; Celeste L Pearce; Anna H Wu; Daniel W Cramer; Kathryn L Terry
Journal:  Int J Cancer       Date:  2017-09-21       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.